loadpatents
name:-0.018187999725342
name:-0.021100997924805
name:-0.00089001655578613
Reel; Jon Kevin Patent Filings

Reel; Jon Kevin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Reel; Jon Kevin.The latest application filed is for "6-substituted-3h-1,3-benzothiazol-2-one compounds as tarp-gamma 8 dependent ampa receptor antagonists".

Company Profile
0.5.7
  • Reel; Jon Kevin - Carmel IN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
6-substituted-3H-1,3-benzothiazol-2-one compounds as TARP-gamma 8 dependent AMPA receptor antagonists
Grant 9,469,632 - Gardinier , et al. October 18, 2
2016-10-18
6-substituted-3h-1,3-benzothiazol-2-one Compounds As Tarp-gamma 8 Dependent Ampa Receptor Antagonists
App 20150344468 - GARDINIER; Kevin Matthew ;   et al.
2015-12-03
6-((S)-1- {1-[5-(2-hydroxy-ethoxy)-pyridin-2-yl]-1H-pyrazol-3-YL}-ethyl)-3- H-1,3-benzothiazol-2-one as a tarp-gamma 8 dependent AMPA receptor antagonist
Grant 8,765,960 - Reel , et al. July 1, 2
2014-07-01
6-((s)-1--ethyl)-3h-1,3-benzothiazol-2-one As A Tarp-gamma 8 Dependent Ampa Receptor Antagonist
App 20140148441 - REEL; Jon Kevin ;   et al.
2014-05-29
Azepine derivatives as gamma-secretase inhibitors
Grant 8,188,069 - Miller , et al. May 29, 2
2012-05-29
Purine Derivatives As Kinase Inhibitors
App 20110294792 - Engler; Thomas Albert ;   et al.
2011-12-01
Purine derivatives as kinase inhibitors
Grant 8,058,425 - Engler , et al. November 15, 2
2011-11-15
Purine derivatives as kinase inhibitors
Grant 8,022,065 - Engler , et al. September 20, 2
2011-09-20
Purine Derivatives As Kinase Inhibitors
App 20110207721 - Engler; Thomas Albert ;   et al.
2011-08-25
Azepine Derivatives As Gamma-secretase Inhibitors
App 20100197660 - Miller; Melinda Joy Hope ;   et al.
2010-08-05
Purine Derivatives As Kinase Inhibitors
App 20090105229 - Engler; Thomas Albert ;   et al.
2009-04-23
Purine derivatives as kinase inhibitors
App 20050090483 - Engler, Thomas Albert ;   et al.
2005-04-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed